Related Experiment Video
Updated: Jun 27, 2026
A Multi-Cue Bioreactor to Evaluate the Inflammatory and Regenerative Capacity of Biomaterials under Flow and Stretch
Published on: December 10, 2020
Evolutions in Cardiovascular Implants-A Review of Past, Present, and Future
Callen Moon1, Jay Ming Tong1,2, Dake Hao1,3
1Department of Surgery, University of California Davis, Sacramento, CA 95817, USA.
Insights
Cardiovascular implants are evolving from basic devices to intelligent, integrated systems. Future research focuses on regenerative materials and smart bioelectronics for improved cardiovascular disease treatment.
Area of Science:
- Biomedical Engineering
- Cardiovascular Medicine
- Materials Science
Background:
- Cardiovascular disease (CVD) is a leading global cause of death.
- Early cardiovascular implants faced limitations like restenosis and poor biocompatibility.
- Next-generation implants aim for better performance and tissue integration.
Purpose of the Study:
- To review the evolution of cardiovascular implants.
- To discuss current applications and emerging technologies.
- To identify challenges and future directions in cardiovascular implant development.
Main Methods:
- Literature review of historical and current cardiovascular implant technologies.
- Analysis of advancements in biomaterials, tissue engineering, and bioelectronics.
- Discussion of biological and engineering challenges and future research avenues.
Main Results:
- Cardiovascular implants have transitioned from passive devices to biologically integrated, intelligent systems.
- Key advancements include improved hemodynamic performance, regenerative potential, and enhanced functionality.
- Emerging technologies focus on regenerative biomaterials, smart bioelectronics, and personalized implants.
Conclusions:
- Significant progress has been made in cardiovascular implant technology.
- Overcoming biological and engineering challenges is crucial for long-term clinical success.
- Future directions promise personalized and intelligent cardiovascular implants for advanced therapies.
Abstract:
Cardiovascular disease (CVD) remains the leading cause of mortality worldwide, driving the continuous evolution of implantable cardiovascular therapies. Although early cardiovascular implants revolutionized the treatment of CVD, they are limited by restenosis, mechanical failure, poor biocompatibility, and inadequate tissue integration. These clinical limitations have driven the development of next-generation implants, with improved hemodynamic performance, regenerative potential, and long-term functionality. Advances in biomaterial science, tissue engineering, biosensors, wireless telemetry, flexible bioelectronics, and translational cardiovascular medicine have transformed cardiovascular implants from passive structural devices into biologically integrated and increasingly intelligent systems capable of interacting dynamically with the host cardiovascular environment. In this review, we summarize the historical evolution, current clinical applications, and emerging technologies of major cardiovascular implants. We further discuss key biological and engineering challenges limiting long-term clinical success and highlight future directions in regenerative biomaterials, smart bioelectronics, and personalized cardiovascular implants for next-generation cardiovascular therapy.
More Related Videos
Related Concept Videos
01:29Cardiomyopathy V: Interprofessional Care
01:16Heart Valves
The AV valves prevent the backflow of blood from the ventricles to the atria during ventricular contraction. These valves function with the assistance of the chordae tendineae and papillary muscles. When the ventricles are relaxed, the chordae tendineae are slack, allowing blood to flow from the atria into the...